Patterns of dispensed disulfiram and naltrexone for alcoholism treatment in a veteran patient population

Alcoholism: Clinical and Experimental Research

Volumn 28, Issue 8, 2004, Pages 1229-1235

  Hermos, John A ^a,b,c   Young, Melissa M ^a   Gagnon, David R ^a,b   Fiore, Louis D ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

Alcoholism Treatment; Disulfiram; Naltrexone; Pharmacoepidemiology

Indexed keywords

ANTIDEPRESSANT AGENT; DISULFIRAM; FLUOXETINE; HYDROCHLOROTHIAZIDE; MEVINOLIN; NALTREXONE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PLACEBO; RISPERIDONE; SERTRALINE; SIMVASTATIN; STATINE DERIVATIVE;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; FOOD AND DRUG ADMINISTRATION; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; SOLDIER; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOLISM; CONFIDENCE INTERVALS; DISULFIRAM; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NALTREXONE; NEW ENGLAND; PRESCRIPTIONS, DRUG; SURVIVAL ANALYSIS; VETERANS;

EID: 4243189323     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000134234.39303.17     Document Type: Article

References (24)

1. Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: result of a placebo-controlled trial. Am J Psychiatry 156:1758-1764.
2. Babor TF, Dolinsky Z, Rounsaville B, Jaffe J (1987) Unitary versus multidimensional models of alcoholism treatment outcome: an empirical study. J Stud Alcohol 49:167-177.
3. Berglund M, Thelander S, Salaspuro M, Franck J, Andreasson S, Ojehagen A (2003) Treatment of alcohol abuse: an evidence-based review. Alcohol Clin Exp Res 27:1645-1656.
4. Clayton DG, Cuzick J (1985) Multivariate generalizations of the proportional hazards model (with discussion). J R Stat Soc A 148:82-117.
5. Cox DR (1972) Regression models and life tables (with discussion) J R Stat Soc B 34:187-220.
6. Cramer JA, Rosenheck R (1998) Compliance with medication regimens for mental and physical disorders. Psychiatr Serv 49:196-201.
7. Finney JW, Moos RH (1992) The long-term course of treated alcoholism: I. Mortality, relapse and remission rates and comparisons with community controls. J Stud Alcohol 52:44-54.
8. Fuller R, Roth H, Lang S (1983) Compliance with disulfiram treatment of alcoholism. J Chron Dis 36:161-170.
9. Fuller RK, Branchey L, Brightwell DR, Derman RM, Emrick CD, Iber FL, et al. (1986) Disulfiram treatment for alcoholism: a Veterans Administrative cooperative study. JAMA 256:1449-1455.
10. Hughes JC, Cook CCH (1997) The efficacy of disulfiram: a review of outcome studies. Addiction 92:381-395.
11. Institute of Medicine (1989) What is being treated? in Broadening the Base of Treatment for Alcohol Problems, pp 23-41. National Academy Press, Washington, DC.
12. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481.
13. Kirchmayer U, Davoli M, Verster AD, Amato L, Ferri A, Perucci CA (2002) A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence. Addiction 97:1241-1249.
14. Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck FA (2001) Natrexone in the treatment of alcohol dependence. N Engl J Med 345:1734-1739.
15. Larson EW, Olincy A, Rummans TA, Morse RM (1992) Disulfiram treatment of patients with both alcohol dependence and other psychiatric disorders: a review. Alcohol Clin Exp Res 16:125-130.
16. Mark TL, Kranzler HR, Song X, Bransberger P, Poole VH, Crosse S (2003) Physicians' opinions about medications to treat alcoholism. Addiction 98:617-626.
17. O'Malley SS, Jaffe A, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 49:881-887.
18. Petrakis IL, Leslie D, Rosenheck R (2003) Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs. Alcohol Clin Exp Res 27:1780-1784.
19. Pettinati HM, Volpicelli JR, Pierce JD, O'Brien CP (2000) Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. J Addict Dis 19:71-83.
20. Polich JM, Armor DJ, Braiker HB (1981) The Course of Alcoholism: Four Years After Treatment. Wiley-Interscience, New York.
21. Schulz JE, Chappel JN (1998) Twelve Step Programs in Principles of Addiction Medicine (Graham AW, Schultz TK eds), 2nd ed, pp 693-706. American Society of Addiction Medicine, Chevy Chase, MD.
22. Streeton C, Whelan G (2001) Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials. Alcohol Alcohol 36:544-552.
23. Thomas CP, Wallack SS, Lee S, McCarty D, Swift R (2003) Research to practice: adoption of naltrexone in alcoholism treatment. J Subst Abuse Treat 24:1-11.
24. Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AL, O'Brien CP (1997) Naltrexone and alcohol dependence: role of subject compliance. Arch Gen Psychiatry 54:737-742.